Preferentially expressed genes in chronic myelogenous leukemia

Area of Science:

• Molecular Biology
• Hematology
• Oncology

Background:

• Chronic myelogenous leukemia (CML) cells share morphological similarities with normal myeloid precursors but exhibit distinct characteristics.
• The Philadelphia chromosome (Ph1) is present in ~88% of CML patients, and leukocyte alkaline phosphatase (LAP) values are typically decreased.
• Investigating gene expression in CML cells is crucial for understanding disease mechanisms and developing diagnostic tools.

Purpose of the Study:

• To identify genes preferentially expressed in chronic myeloid leukemia (CML) cells.
• To construct a complementary DNA (cDNA) library from CML patient RNA for gene discovery.
• To select and characterize novel gene sequences expressed in CML.

Main Methods:

• Construction of a cDNA library from poly(A+)RNA of a chronic-phase, Ph1-positive CML patient.
• Selection of recombinant clones by hybridization with radiolabeled cDNA and assessment of radioactivity.
• Screening of selected clones against normal placenta, acute myelomonocytic leukemia (AMML), and other CML samples to identify CML-specific sequences.

Main Results:

• Out of 729 initial colonies, 417 (57.2%) contained sequences homologous to moderately or highly expressed RNAs.
• Six out of eight further analyzed clones showed preferential expression in CML.
• One clone, C-A3, demonstrated high expression in both Ph1-positive and Ph1-negative CML chronic phases and Ph1-positive acute myelogenous leukemia (AML), with reduced or absent expression in CML crisis phases.

Conclusions:

• The identified C-A3 sequence is preferentially expressed in various CML subtypes.
• The C-A3 probe may serve as a diagnostic aid for Ph1-negative CML.
• This probe could help differentiate myeloblastic crisis of CML (M BC-CML) from lymphoblastic crisis of CML (L BC-CML) and Ph1-positive AML.